首頁 > 市場調查報告書 > 醫療設備

導管泌尿科

市場調查報告書

商品編碼

1643904

全球輸尿管支架市場 - 2025-2033

Global Ureteral Stents Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 209 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球輸尿管支架市場達到5.2145億美元，預計2033年將達到8.5024億美元，2025-2033年預測期間複合年成長率為5.8%。

輸尿管支架是放置在輸尿管中的一根薄的軟性管，它將尿液從腎臟轉移到膀胱。其主要功能是預防或治療干擾尿流的阻塞，這種阻塞可能是由腎結石、腫瘤或狹窄等許多醫療問題引起的。輸尿管支架的設計目的是保持輸尿管足夠寬，使尿液能夠正確地從腎臟流到膀胱。他們經常在堵塞的情況下使用。

對輸尿管支架的需求不斷成長是預測期內推動市場的促進因素。這種需求的增加可能與各種相互關聯的原因有關，包括泌尿系統問題的盛行率上升、老年人口的增加以及支架技術的進步。所有這些因素共同增加了對輸尿管支架的需求並推動了市場的發展。

市場動態：

驅動程式和限制

輸尿管支架的需求不斷增加

對輸尿管支架的需求不斷成長預計將成為全球輸尿管支架市場成長的重要因素。由於腎臟相關疾病數量的增加、投資的增加和技術的進步，全球輸尿管支架市場可望大幅擴張。腎臟相關疾病發生率的上升對輸尿管支架需求的增加產生了重大影響。

例如，根據美國國立衛生研究院的數據，慢性腎臟病是一種進行性疾病，影響著全球 10% 以上的人口，即全球 8 億多人。此外，根據美國國家腎臟基金會的數據，全球有超過 200 萬人正在接受透析或腎臟移植治療以維持生命，然而，這項估計可能只代表實際需要治療才能生存的人的 10%。隨著這些問題變得越來越普遍，對輸尿管支架置入術等有效治療的需求也隨之增加。

近年來，許多資金和投資被用於輸尿管支架的研究、開發和製造。例如，2024 年 11 月，泰米爾納德邦政府與美國路博潤簽署了一份合作備忘錄 (MoU)。此次合作耗資約 20 億印度盧比，為輸尿管支架、神經血管和心血管治療、靜脈導管、血液透析管和中心靜脈導管等關鍵應用生產高品質醫用管材。投資的增加，增加了輸尿管支架的產量，以滿足輸尿管支架不斷成長的需求，並帶動了市場。

支架取出後併發症的高風險

支架移除後併發症的高風險等因素預計將阻礙全球輸尿管支架市場。感染、血尿和急性疼痛等併發症可能會對患者的生活品質產生重大影響，從而增加患者使用這些設備的意願。刺激性排尿症狀，例如尿急、頻尿和不適，是支架移除後最常見的後果之一。此外，切除後可能會出現更嚴重的併發症，例如泌尿道感染和長時間出血，需要額外的手術治療。對這些潛在後果的恐懼可能會導致患者變得焦慮，泌尿科醫生可能不願意建議支架置入術作為第一線治療選擇。

A ureteral stent is a thin, flexible tube placed in the ureter, which transfers urine from the kidneys to the bladder. Its major function is to prevent or treat obstructions that interfere with urine flow, which can be caused by a number of medical problems such as kidney stones, tumors, or strictures. Ureteral stents are designed to keep the ureter wide enough for urine to pass properly from the kidney to the bladder. They are frequently employed in situations where there is a blockage.

The increasing demand for ureteral stents is the driving factor that drives the market over the forecast period. This increase in demand can be linked to various interrelated causes, including the rising prevalence of urological problems, the increasing geriatric population, and advances in stent technology. All these factors together increase the demand for ureteral stents and it drives the market.

Market Dynamics: Drivers & Restraints

Increasing demand for ureteral stents

The increasing demand for ureteral stents is expected to be a significant factor in the growth of the global ureteral stents market. The global ureteral stents market is poised for significant expansion, owing to the rising number of kidney-related disorders, increasing investments, and technological advancements. The rising incidence of kidney-related conditions has a substantial impact on the increasing demand for ureteral stents.

For instance, according to the National Institute of Health, chronic kidney disease is a progressive disorder that affects more than 10% of the world's population, or over 800 million people across the globe. Moreover, according to the National Kidney Foundation, over 2 million people worldwide are receiving treatment with dialysis or a kidney transplant to stay alive, however, this estimate may only represent 10% of people who actually need treatment for their survival. As these problems become increasingly common, the demand for effective treatments, such as ureteral stenting, has increased.

In recent times, many funds and investments have been made for research, development, and manufacture of ureteral stents. For instance, in November 2024, The Tamil Nadu government and Lubrizol, based in the United States, signed a Memorandum of Understanding (MoU). The partnership, which cost approximately INR 200 crore, generated high-quality medical tubing for key applications such as ureteral stents, neurovascular and cardiovascular treatments, intravenous catheters, hemodialysis tubes, and central venous catheters. The increased investments, increase the production volume of the ureteral stents to meet the increasing demand for ureteral stents and it drives the market.

High risk of complications post-stent removal

Factors such as the high risk of complications post-stent removal are expected to hamper the global ureteral stents market. Complications such as infection, hematuria, and acute pain can have a major impact on patient quality of life, increasing reluctance to use these devices. Irritative voiding symptoms, such as increased urine urgency, frequency, and discomfort, are one of the most prevalent consequences of stent removal. Furthermore, more serious complications such as urinary tract infections and prolonged bleeding may occur following removal, necessitating additional surgical treatments. Fear of these potential consequences can cause patients to become anxious, and urologists might become reluctant to suggest stenting as a first-line treatment option.

Segment Analysis

The Global Ureteral Stents Market is segmented based on Product Type, Material, Application, End-User, And Region.

Double pigtail stents segment is expected to dominate the global ureteral stents market share

The double pigtail stents segment is anticipated to dominate the global ureteral stents market owing to their unique design, featuring coiled ends and technological advancements.

These stents are distinguished by their unique shape, which includes coiled ends that assist anchor the stent within the urinary tract, successfully avoiding migration and ensuring solid placement. This design not only reduces the risk of issues associated with stent displacement but also allows for better compliance with the anatomical structure of the urinary system, thereby improving patient comfort during use. This unique shape of the stent makes it user-friendly for the patients and increases the demand for the double pigtail stents making this the most dominating segment in the global ureteral stents market.

Recent technological advancements and launches have boosted the acceptance of double pigtail stents. For instance, in December 2024, The RELIEF ureteral stent was approved as the first and only stent for the prevention of vesicoureteral reflux, which is a major source of patient discomfort. Technological improvements and recent launches such as RELIEF ureteral stents have aided the development of minimally invasive insertion techniques for double pigtail stents. These procedures not only improve the simplicity of implantation but also minimize recuperation time for patients, increasing their acceptance in medical facilities and making them the most dominating segment in the global ureteral stents market.

Geographical Analysis

North America is expected to hold a significant position in the global ureteral stents market share

North America is expected to hold a significant portion of the global ureteral stents market. North America will likely account for a significant share of the global ureteral stents market, owing to its rising number of kidney-related disorders, increasing healthcare investments, advanced healthcare infrastructure, and technological advancements. One of the primary drivers of this demand in North America is the single number of kidney-related disorders.

For instance, according to the American Kidney Fund, more than 35.5 million Americans suffer from kidney disease. An estimated 808,000 Americans suffer from kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is spreading at an alarming rate. It currently affects more than one in every seven (14% of American adults). In 2021, more than 135,000 Americans were diagnosed with kidney failure. Nine out of 10 individuals with renal disease were unaware of their status, and one-third of those with severely impaired kidney function were also unaware. Due to the increasing number of kidney-related disorders, the need for ureteral stents is increasing which helps ensure proper flow of urine through the ureter, this increases the demand for ureteral stents and drives the market in North America.

Asia Pacific is growing at the fastest pace in the global ureteral stents market

The Asia Pacific region is emerging as the fastest-growing market for ureteral stents, owing to a rising prevalence of urological disorders, increasing healthcare investments, and technological advancements. The increasing number of kidney-related disorders and renal replacement therapies are the primary reasons for the upsurge and growth of the market in the Asia Pacific region. For instance, the estimated prevalence of CKD is 800 per million people (pmp), while the incidence of end-stage renal disease (ESRD) is 150-200 pmp. Diabetic nephropathy is the leading cause of chronic kidney disease in population-based research. In India, nearly 18,000-20,000 patients (10% of new ESRD cases) receive renal replacement therapy, with over 172 transplant centers, the majority of which are privately run and located in South India. Each year, nearly 3,500 transplants are performed, with approximately 700 cadaver donors. Due to the increasing number of kidney-related disorders, the improper flow of urine is increasing which increases the demand for the ureteral stents market in the Asia Pacific region.

Competitive Landscape

The major global players in the global ureteral stents market include Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, Coloplast Ltd., BD, Medline Industries, Inc., Allium Medical Solutions Ltd, Pnn Medical A/S, Teleflex Incorporated, Olympus Corporation among others.

Emerging Players

Mitra Industries, InVivo Bionics, and ZygoFix among others

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ureteral stents market report delivers a detailed analysis with 70+ key tables, more than 60 visually impactful figures, and 250 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increasing Demand for Ureteral Stents
4.2. Restraints
- 4.2.1. High Risk of Complications Post-stent Removal
- 4.2.2. Opportunity
- 4.2.3. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Multiloop*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Open-end stents
6.4. Closed-end stents
6.5. Double pigtail stents

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Metal stents*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Silicone stents
7.4. Hybrid stents
7.5. Polyurethane stents
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Kidney stones*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Kidney transplantation
8.4. Tumors
8.5. Urinary incontinence
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Boston Scientific Corporation*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. B. Braun Holding GmbH & Co. KG
12.3. Cook Group Incorporated
12.4. Coloplast Ltd.
12.5. BD
12.6. Medline Industries, Inc.
12.7. Allium Medical Solutions Ltd
12.8. Pnn Medical A/S
12.9. Teleflex Incorporated
12.10. Olympus Corporation

LIST NOT EXHAUSTIVE